Caterina Maria Gambino

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

Bruna Lo Sasso, Rosaria Vincenza Giglio, Matteo Vidali et al. · Diagnostics · 2021 · 100 citations · Full text

Neurogranin as a Novel Biomarker in Alzheimer’s Disease

Luisa Agnello, Caterina Maria Gambino, Bruna Lo Sasso et al. · Laboratory Medicine · 2020 · 69 citations

Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study

Luisa Agnello, Bruna Lo Sasso, Rosaria Vincenza Giglio et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2020 · 47 citations

Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients

Giuliana Guggino, Marianna Lo Pizzo, Diana Di Liberto et al. · Clinical & Experimental Immunology · 2017 · 44 citations · Full text

Ssc Patients, Lymphocyte Development, Immunology +25

Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine

Bruna Lo Sasso, Luisa Agnello, Rosaria Vincenza Giglio et al. · Scientific Reports · 2022 · 43 citations · Full text